Sort by
Refine Your Search
-
of the IP. Clinical follow-up of patients after hospital discharge according to the guidelines and roadmaps under the supervision of the Principal Investigator. Collaboration in the design, management and
-
generation of dually loaded self-assembled peptide lipid nanoparticles enabling glaucoma neuroprotection. IP: Elena Sánchez López Research group: Nanostructurated Systems for controlled drug release
-
cells and human iPS cells, as well as with genetically modified mouse and pig models. Last publications: https://pubmed.ncbi.nlm.nih.gov/40551151/ https://pubmed.ncbi.nlm.nih.gov/37967560/ https
-
. - Collaborate with a multidisciplinary team and industry partners. - Present results and contribute to publications. Where to apply Website https://t.ly/wxZC_ Requirements Research FieldBiological
-
, optogenetics (light-activated phytochromes), combined with behavioral and fMRI measurements in the context of Huntington’s Disease. Where to apply Website http://www.ub.edu/caiac/solBeca?idConvocatoria=50399